The present disclosure relates to a cancer killer cell in which a therapeutic recombinant protein or recombinant protein which improves cytotoxic activity of the cancer killer cell is loaded. In addition, the present invention relates to a pharmaceutical composition comprising the recombinant protein or a recombinant protein-loaded cancer killer cell. Further, the present invention relates to a method for preparing a recombinant protein-loaded cancer killer cell.